TaqMan | GenomeWeb

TaqMan

Roughly one-fifth of adult cases of acute lymphoblastic leukemia are marked by Philadelphia chromosome-like expression. 

Researchers in Belgium and the UK showed that their custom viral panel on Thermo Fisher's TaqMan qPCR array card is effective in samples from immunocompromised patients.

The assays add to the test menu of Beckman Coulter's DxN Veris molecular diagnostics system.

The strategy could be applied more widely to study the development of other organ systems, and will benefit from new single-cell gene expression analysis technology.

Thermo Fisher Scientific this week announced the release of the QuantStudio 3D Rare Mutation Analysis solution.

NEW YORK (GenomeWeb) – Roche today announced the launch of the Global Access Program for HIV viral load testing.

Life Technologies, a Thermo Fisher Scientific brand, said this week that it has launched TaqMan multiplex reagents.

Scientists from the Stanford University School of Medicine and the Stanford Genome Technology Center have demonstrated proof of principle for performing high-sensitivity detection and quantification of DNA copy number and SNPs on Bio-Rad's droplet digital PCR platform using a sin

NEW YORK (GenomeWeb News) – Copy number and expression shifts involving cytokine immune genes in colorectal cancer samples can offer insights into immune involvement in the disease and its propensity for progression, a new study suggests.

A team of scientists from Japan's Riken and DNAForm has developed a highly efficient fluorescent molecular probe for combined real-time PCR monitoring and melting curve analysis, according to research published this week in

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.